Trimethoprim-Sulphamethoxazole in Enteric Fevers
British Medical journal, 1970, 3, 323-324 S ummary: Clinical improvement was rapid in all 13 patients with enteric fever and one with Brucella abortus iMection treated with trimethoprimsulphamethoxazole. There were no side-effects of the treatnent and it was found easy to administer to toxic and delirious patients.
Trimethoprim-sulphamethoxazole has been successfully used in the treatment of urinary tract infections (Gruneberg and Kolbe, 1969; Reeves et al, 1969) , gonorrhoea (British Medical 7ournal, 1969) , chronic bronchitis (Hughes, 1969) , and Gramnegative septicaemia (Noall et al., 1962) . Except for one report from Nigeria by Akinkugbe et al. (1968) there have been few well-controlled studies on its use in typhoid fevers. We report here on use of the substance in the treatment of 13 patients with enteric fever and one patient with proved Brucella abortus septicaemia.
Materials and Methods
The study was conducted during the last three weeks of February 1970. Of the 14 patients included in the study 7 were males and 7 were females; all lived in Cairo. Their ages ranged from 5 to 16 years. All were very sick and toxic before treatment was started, and all had a temperature of 104°F. (400C.) or above. In every case examination revealed a thickly-coated white tongue, abdominal distension with tympanitis, and a soft tender palpable spleen.
Blood cultures were performed on double-phase Castaneda bottles (Castaneda, 1947) and on ox bile (Kaye et al., 1966) , and urine and stool cultures were made on selective media on selenite broth. Three blood specimens, one urine, and one stool specimen were obtained before starting treatnent. Subsequentiy, blood, urine, and stool cultures were performed twice weekly during treatment and for three weeks after treatment.
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Addendum
Two additional patients were treated with trimethoprimsulphamethoxazole (two tablets every 12 hours for 10 days). The first patient was a young man aged 15 who was admitted to hospital acutely sick, with a temperature of 1040F. (400C.); his blood culture was positive for Saim. paratyphi A. The second patient was a woman aged 16 years who gave a history of recurrent febrile attacks of one year's duration. Her brucella agglutination titre was 1/1640 and her blood culture was positive for Brucella melitensis. Both patients responded promptly to treatment, were asymptomatic and afebrile within five days of starting therapy, and have remained well up to the time of writing, three weeks after the end of treatment.
INTRODUCTION
The rate at which administered isoniazid disappears from the circulation is genetically determined. The two major phenotypes, rapid and slow inactivators (Hughes et al., 1954; Harris et al., 1958) , differ in the rate of hepatic acetylation of the drug (Evans and White, 1964; Goedde et al., 1964) . The acetylator phenotype does not affect the outcome of tuberculosis treatment with standard dosage regimens (Evans et al., 1960) . Rapid inactivators, however, respond less well to a once-weekly dosage regimen (Menon, 1968) , and develop isoniazid resistance sooner, than slow inactivators (Tripathy, 1968) . Thus there is increasing interest in determining acetylator phenotype. Some new methods have been proposed (Evans, 1969; Tiitinen, 1969) but simpler techniques suitable for routine screening in developing countries are still required.
The ratio of acetylisoniazid to isoniazid (A:I) in the urine after an oral dose of the drug distinguishes rapid from slow inactivators (Peters et al., 1965) . A method is here described for estimating this ratio by simple colour tests. The ratio is bimodally distributed in volunteers receiving isoniazid daily. On the basis of these results a simple method for acetylator phenotyping is proposed.
SUBJECTS AND METHODS
Healthy adult volunteers swallowed--100 mg. of isoniazid three times daily after meals for five days. On the second and following days morniing urine was collected and analysed.
Analysis for Acetylisoniazid.-The method used was adapted from that of Venkataraman et al. (1968) . Urine (4 drops) was placed in a test-tube, internal diameter 0.8 cm., and treated with 10% w/w potassium cyanide (4 drops), followed after mixing by 10% w/w chloramine T (9 drops). After one minute the contents were again mixed. One minute later acetone (0-2 ml.) was added. After remixing, the concentration of acetylisoniazid was determined by comparison with standards of acetylisoniazid in normal drug-free urine (320, 160, 80, 40, 20 , and 0 ,ig./ml.) which were treated in the same way. To each sample was allotted a nominal acetylisoniazid concentration equal to that of the standard which it matched or immediately exceeded in depth of colour. Thus a sample intermediate in colour between the 80 and 160 ,ug./ml. standards was allotted a nominal concentration of 80 ug./ml. The actual colour varied between pink and orange, depending on the concentration of the urine; comparison was made with respect to depth of colour rather than hue.
Analysis for Free Isoniazid.-The method used was adapted from that of Dymond and Russell (1970) for determining isoniazid in blood. The sample (20 drops) was treated with 50% (w/w) dipotassium hydrogen phosphate (10 drops) followed by a solution (1.25 %) of 2,4,6-trinitrobenzenesulphonic acid in methyl isobutyl ketone (0.25 ml.) The contents were mixed vigorously for 10 seconds, allowed to stand for two minutes, mixed again tigorously for 20 seconds, and briefly centrifuged. The concentration of isoniazid in the sample was determined by comparison with standards of isoniazid in normal drug-free urine (64, 32, 16, 8, 4 , 2, and 0 ,ug./ml.), which were treated in the same way.-The orange colour due to isoniazid was in the upper phase; the lower phase was ignored. To each sample a nominal isoniazid concentration was allotted in the same way as for acetylisoniazid.
Notes on the Methods.-Aqueous reagents were measured from Pasteur pipettes held at an angle of approximately 45°.
One pipette was used for all unrne samples and standards and one for each aqueous reagent. For organic liquids a graduated pipette was used. Mixing was done with a Vortex Genie mixer (Scientific Industries, Springfield, Mass., U.S.A.). For each sample a "nominal A: I ratio" was calculated from the nominal concentrations.
